AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-82
Results: 1-25/82
ADJUVANT RADIOTHERAPY AND FOLLOW-ON CHEMOTHERAPY IN PATIENTS WITH PANCREATIC-CANCER - RESULTS OF THE UK PANCREATIC-CANCER GROUP-STUDY (UKPACA-1)
Authors: NEOPTOLEMOS JP
Citation: Jp. Neoptolemos, ADJUVANT RADIOTHERAPY AND FOLLOW-ON CHEMOTHERAPY IN PATIENTS WITH PANCREATIC-CANCER - RESULTS OF THE UK PANCREATIC-CANCER GROUP-STUDY (UKPACA-1), GI cancer, 2(3), 1998, pp. 235-245
ACUTE CHOLANGITIS AND PANCREATITIS SECONDARY TO COMMON DUCT STONES - MANAGEMENT UPDATE
Authors: RARATY MGT FINCH M NEOPTOLEMOS JP
Citation: Mgt. Raraty et al., ACUTE CHOLANGITIS AND PANCREATITIS SECONDARY TO COMMON DUCT STONES - MANAGEMENT UPDATE, World journal of surgery, 22(11), 1998, pp. 1155-1161
ACUTE-PANCREATITIS AS A MODEL OF SEPSIS
Authors: WILSON PG MANJI M NEOPTOLEMOS JP
Citation: Pg. Wilson et al., ACUTE-PANCREATITIS AS A MODEL OF SEPSIS, Journal of antimicrobial chemotherapy, 41, 1998, pp. 51-63
ACUTE-PANCREATITIS - THE SUBSTANTIAL HUMAN AND FINANCIAL COSTS
Authors: NEOPTOLEMOS JP RARATY M FINCH M SUTTON R
Citation: Jp. Neoptolemos et al., ACUTE-PANCREATITIS - THE SUBSTANTIAL HUMAN AND FINANCIAL COSTS, Gut, 42(6), 1998, pp. 886-891
DOES EARLY ERCP+ -ES REDUCE THE MORBIDITY AND MORTALITY OF ACUTE GALLSTONE PANCREATITIS - A METAANALYSIS OF ACUTE GALLSTONE/
Authors: SOETIKNO RM CARRLOCKE DL NEOPTOLEMOS JP FAN ST FOELSCH U MAREK TA NOVAK A
Citation: Rm. Soetikno et al., DOES EARLY ERCP+ -ES REDUCE THE MORBIDITY AND MORTALITY OF ACUTE GALLSTONE PANCREATITIS - A METAANALYSIS OF ACUTE GALLSTONE/, Gastrointestinal endoscopy, 47(4), 1998, pp. 424-424
PREDICTION OF RESECTABILITY OF PANCREATIC MALIGNANCY BY COMPUTED-TOMOGRAPHY
Authors: MCCARTHY MJ EVANS J SAGAR G NEOPTOLEMOS JP
Citation: Mj. Mccarthy et al., PREDICTION OF RESECTABILITY OF PANCREATIC MALIGNANCY BY COMPUTED-TOMOGRAPHY, British Journal of Surgery, 85(3), 1998, pp. 320-325
LOW MORTALITY FOLLOWING RESECTION FOR PANCREATIC AND PERIAMPULLARY TUMORS IN 1026 PATIENTS - UK SURVEY OF SPECIALIST PANCREATIC UNITS - REPLY
Authors: SLAVIN J BRAMHALL S RUSSELL RCG NEOPTOLEMOS JP
Citation: J. Slavin et al., LOW MORTALITY FOLLOWING RESECTION FOR PANCREATIC AND PERIAMPULLARY TUMORS IN 1026 PATIENTS - UK SURVEY OF SPECIALIST PANCREATIC UNITS - REPLY, British Journal of Surgery, 85(3), 1998, pp. 426-427
P53 AND P16 GENE-THERAPY RESULTS IN KILLING OF PANCREATIC-CANCER CELLS
Authors: GHANEH P HUMPHREYS M GREENHALF W LEMOINE N NEOPTOLEMOS JP
Citation: P. Ghaneh et al., P53 AND P16 GENE-THERAPY RESULTS IN KILLING OF PANCREATIC-CANCER CELLS, British Journal of Surgery, 85(11), 1998, pp. 1555-1555
ALLELIC DELETION AT 8P11-CENTER-DOT-2 IS FREQUENT IN HEAD AND NECK-CANCER AND IDENTIFIABLE USING FLUORESCENT IN-SITU HYBRIDIZATION ON TUMORIMPRINTS
Authors: KUO MJ CRUNDWELL MC KNOWLES M WATKINSON JC OATES J WARFIELD AT MORTON DG NEOPTOLEMOS JP
Citation: Mj. Kuo et al., ALLELIC DELETION AT 8P11-CENTER-DOT-2 IS FREQUENT IN HEAD AND NECK-CANCER AND IDENTIFIABLE USING FLUORESCENT IN-SITU HYBRIDIZATION ON TUMORIMPRINTS, British Journal of Surgery, 85(11), 1998, pp. 1563-1563
FREQUENT LOSS OF 5Q21 IN HEAD AND NECK-CANCER WITHOUT INACTIVATION OFTHE APC GENE IMPLIES THE PRESENCE OF ANOTHER PUTATIVE TUMOR-SUPPRESSOR GENE AT 5Q21
Authors: KUO MJ MACKAY SJ OATES J WARFIELD AT WATKINSON JC MORTON DG NEOPTOLEMOS JP
Citation: Mj. Kuo et al., FREQUENT LOSS OF 5Q21 IN HEAD AND NECK-CANCER WITHOUT INACTIVATION OFTHE APC GENE IMPLIES THE PRESENCE OF ANOTHER PUTATIVE TUMOR-SUPPRESSOR GENE AT 5Q21, British Journal of Surgery, 85(11), 1998, pp. 1575-1576
EARLY PROSTATE-CANCER IS ASSOCIATED WITH CHANGES IN PROTEIN-KINASE-C ISOENZYME EXPRESSION
Authors: CORNFORD PA EVANS JD PARSONS KF FOSTER CS NEOPTOLEMOS JP
Citation: Pa. Cornford et al., EARLY PROSTATE-CANCER IS ASSOCIATED WITH CHANGES IN PROTEIN-KINASE-C ISOENZYME EXPRESSION, British Journal of Surgery, 85(11), 1998, pp. 1577-1577
EXPRESSION OF BCL(XL) CORRELATES WITH SURVIVAL IN PANCREATIC-CANCER
Authors: EVANS JD CORNFORD PA DODSON A FOSTER CS NEOPTOLEMOS JP
Citation: Jd. Evans et al., EXPRESSION OF BCL(XL) CORRELATES WITH SURVIVAL IN PANCREATIC-CANCER, British Journal of Surgery, 85(11), 1998, pp. 1589-1589
EFFECTS OF P53 AND P16 TRANSFER IN PANCREATIC-CANCER CELLS
Authors: GHANEH P HUMPHREYS M GREENHALF W LEMOINE NR NEOPTOLEMOS JP
Citation: P. Ghaneh et al., EFFECTS OF P53 AND P16 TRANSFER IN PANCREATIC-CANCER CELLS, British Journal of Cancer, 78, 1998, pp. 67-67
THE TIMING OF ENDOSCOPIC SPHINCTEROTOMY IN GALLSTONE ACUTE-PANCREATITIS
Authors: WILSON PG OGUNBIYI O NEOPTOLEMOS JP
Citation: Pg. Wilson et al., THE TIMING OF ENDOSCOPIC SPHINCTEROTOMY IN GALLSTONE ACUTE-PANCREATITIS, European journal of gastroenterology & hepatology, 9(2), 1997, pp. 137-144
CHOLEDOCHOLITHIASIS AND GALLSTONE PANCREATITIS
Authors: RARATY MGT POPE IM FINCH M NEOPTOLEMOS JP
Citation: Mgt. Raraty et al., CHOLEDOCHOLITHIASIS AND GALLSTONE PANCREATITIS, Bailliere's clinical gastroenterology, 11(4), 1997, pp. 663-680
SENSITIZATION OF COLORECTAL AND PANCREATIC-CANCER CELL-LINES TO THE PRODRUG 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) BY RETROVIRAL TRANSDUCTION AND EXPRESSION OF THE ESCHERICHIA-COLI NITROREDUCTASE GENE
Authors: GREEN NK YOUNGS DJ NEOPTOLEMOS JP FRIEDLOS F KNOX RJ SPRINGER CJ ANLEZARK GM MICHAEL NP MELTON RG FORD MJ YOUNG LS KERR DJ SEARLE PF
Citation: Nk. Green et al., SENSITIZATION OF COLORECTAL AND PANCREATIC-CANCER CELL-LINES TO THE PRODRUG 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) BY RETROVIRAL TRANSDUCTION AND EXPRESSION OF THE ESCHERICHIA-COLI NITROREDUCTASE GENE, Cancer gene therapy, 4(4), 1997, pp. 229-238
THE NEED FOR A MULTIDISCIPLINARY APPROACH IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER - A CRITICAL-REVIEW FROM A MEDICAL ONCOLOGIST AND SURGEON
Authors: ROUGIER P NEOPTOLEMOS JP
Citation: P. Rougier et Jp. Neoptolemos, THE NEED FOR A MULTIDISCIPLINARY APPROACH IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER - A CRITICAL-REVIEW FROM A MEDICAL ONCOLOGIST AND SURGEON, European journal of surgical oncology, 23(5), 1997, pp. 385-396
SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTORS (IGF-I AND IGP-II) AND THEIR BINDING-PROTEIN (IGFBP-3) ARE NOT ELEVATED IN PANCREATIC-CANCER
Authors: EVANS JD EGGO MC DONOVAN IA BRAMHALL SR NEOPTOLEMOS JP
Citation: Jd. Evans et al., SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTORS (IGF-I AND IGP-II) AND THEIR BINDING-PROTEIN (IGFBP-3) ARE NOT ELEVATED IN PANCREATIC-CANCER, International journal of pancreatology, 22(2), 1997, pp. 95-100
PROGRESS REPORT - A RANDOMIZED MULTICENTER EUROPEAN STUDY COMPARING ADJUVANT RADIOTHERAPY, 6-MO CHEMOTHERAPY, AND COMBINATION THERAPY, VS NO-ADJUVANT TREATMENT IN RESECTABLE PANCREATIC-CANCER (ESPAC-1)
Authors: NEOPTOLEMOS JP BAKER P BEGER H LINK K PEDERZOLI P BASSI C DERVENIS C FRIESS H BUCHLER M
Citation: Jp. Neoptolemos et al., PROGRESS REPORT - A RANDOMIZED MULTICENTER EUROPEAN STUDY COMPARING ADJUVANT RADIOTHERAPY, 6-MO CHEMOTHERAPY, AND COMBINATION THERAPY, VS NO-ADJUVANT TREATMENT IN RESECTABLE PANCREATIC-CANCER (ESPAC-1), International journal of pancreatology, 21(2), 1997, pp. 97-104
ADJUVANT CHEMOTHERAPY IN PANCREATIC-CANCER
Authors: BRAMHALL SR NEOPTOLEMOS JP
Citation: Sr. Bramhall et Jp. Neoptolemos, ADJUVANT CHEMOTHERAPY IN PANCREATIC-CANCER, International journal of pancreatology, 21(1), 1997, pp. 59-63
CHRONIC-PANCREATITIS AND PANCREATIC-CARCINOMA
Authors: EVANS JD MORTON DG NEOPTOLEMOS JP
Citation: Jd. Evans et al., CHRONIC-PANCREATITIS AND PANCREATIC-CARCINOMA, Postgraduate medical journal, 73(863), 1997, pp. 543-548
IMBALANCE OF EXPRESSION OF MATRIX METALLOPROTEINASES (MMPS) AND TISSUE INHIBITORS OF THE MATRIX METALLOPROTEINASES (TIMPS) IN HUMAN PANCREATIC-CARCINOMA
Authors: BRAMHALL SR NEOPTOLEMOS JP STAMP GWH LEMOINE NR
Citation: Sr. Bramhall et al., IMBALANCE OF EXPRESSION OF MATRIX METALLOPROTEINASES (MMPS) AND TISSUE INHIBITORS OF THE MATRIX METALLOPROTEINASES (TIMPS) IN HUMAN PANCREATIC-CARCINOMA, Journal of pathology, 182(3), 1997, pp. 347-355
NOVEL APPROACHES TO TREATING PANCREATIC-CANCER
Authors: NEOPTOLEMOS JP
Citation: Jp. Neoptolemos, NOVEL APPROACHES TO TREATING PANCREATIC-CANCER, Gut, 41, 1997, pp. 76-76
PANCREATIC ACINAR CELL SECRETION OF CYTOKINES IN HUMANS - A POSSIBLE UNIFYING REASON FOR THE DEVELOPMENT OF ACUTE-PANCREATITIS DUE TO DIFFERENT STIMULI
Authors: WILSON PG HASTIE RF JAMES RF NEOPTOLEMOS JP ADAMS DH
Citation: Pg. Wilson et al., PANCREATIC ACINAR CELL SECRETION OF CYTOKINES IN HUMANS - A POSSIBLE UNIFYING REASON FOR THE DEVELOPMENT OF ACUTE-PANCREATITIS DUE TO DIFFERENT STIMULI, Gut, 41, 1997, pp. 135-135
GENE-THERAPY FOR PANCREATIC-CANCER - IN-VIVO KILLING OF TUMOR-CELLS EXPRESSING ESCHERICHIA-COLI NITROREDUCTASE FOLLOWING ADMINISTRATION OF THE PRODRUG CB1954
Authors: GREEN NK YOUNGS DJ YOUNG LS KERR DJ NEOPTOLEMOS JP SEARLE PF
Citation: Nk. Green et al., GENE-THERAPY FOR PANCREATIC-CANCER - IN-VIVO KILLING OF TUMOR-CELLS EXPRESSING ESCHERICHIA-COLI NITROREDUCTASE FOLLOWING ADMINISTRATION OF THE PRODRUG CB1954, Gut, 41, 1997, pp. 188-188
Risultati: 1-25 | 26-50 | 51-75 | 76-82